Literature DB >> 30010625

The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis.

Motoyuki Tsuda1, Akihisa Fukuda1, Nilotpal Roy2, Yukiko Hiramatsu1, Laura Leonhardt2, Nobuyuki Kakiuchi1,3, Kaja Hoyer3,4, Satoshi Ogawa1, Norihiro Goto1, Kozo Ikuta1, Yoshito Kimura1, Yoshihide Matsumoto1, Yutaka Takada1, Takuto Yoshioka1, Takahisa Maruno1, Yuichi Yamaga1, Grace E Kim5, Haruhiko Akiyama6, Seishi Ogawa3, Christopher V Wright7, Dieter Saur8, Kyoichi Takaori9, Shinji Uemoto9, Matthias Hebrok2, Tsutomu Chiba1,10, Hiroshi Seno1.   

Abstract

Chromatin remodeler Brahma related gene 1 (BRG1) is silenced in approximately 10% of human pancreatic ductal adenocarcinomas (PDAs). We previously showed that BRG1 inhibits the formation of intraductal pancreatic mucinous neoplasm (IPMN) and that IPMN-derived PDA originated from ductal cells. However, the role of BRG1 in pancreatic intraepithelial neoplasia-derived (PanIN-derived) PDA that originated from acinar cells remains elusive. Here, we found that exclusive elimination of Brg1 in acinar cells of Ptf1a-CreER; KrasG12D; Brg1fl/fl mice impaired the formation of acinar-to-ductal metaplasia (ADM) and PanIN independently of p53 mutation, while PDA formation was inhibited in the presence of p53 mutation. BRG1 bound to regions of the Sox9 promoter to regulate its expression and was critical for recruitment of upstream regulators, including PDX1, to the Sox9 promoter and enhancer in acinar cells. SOX9 expression was downregulated in BRG1-depleted ADMs/PanINs. Notably, Sox9 overexpression canceled this PanIN-attenuated phenotype in KBC mice. Furthermore, Brg1 deletion in established PanIN by using a dual recombinase system resulted in regression of the lesions in mice. Finally, BRG1 expression correlated with SOX9 expression in human PDAs. In summary, BRG1 is critical for PanIN initiation and progression through positive regulation of SOX9. Thus, the BRG1/SOX9 axis is a potential target for PanIN-derived PDA.

Entities:  

Keywords:  Cancer; Epigenetics; Gastroenterology; Mouse models; Oncology

Mesh:

Substances:

Year:  2018        PMID: 30010625      PMCID: PMC6063489          DOI: 10.1172/JCI94287

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.

Authors:  Akihisa Fukuda; Sam C Wang; John P Morris; Alexandra E Folias; Angela Liou; Grace E Kim; Shizuo Akira; Kenneth M Boucher; Matthew A Firpo; Sean J Mulvihill; Matthias Hebrok
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

Review 3.  Cystic precursors to invasive pancreatic cancer.

Authors:  Hanno Matthaei; Richard D Schulick; Ralph H Hruban; Anirban Maitra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03       Impact factor: 46.802

4.  Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma.

Authors:  Janel L Kopp; Guido von Figura; Erin Mayes; Fen-Fen Liu; Claire L Dubois; John P Morris; Fong Cheng Pan; Haruhiko Akiyama; Christopher V E Wright; Kristin Jensen; Matthias Hebrok; Maike Sander
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

5.  Regulation of pancreatic juxtaductal endocrine cell formation by FoxO1.

Authors:  Tadahiro Kitamura; Yukari Ido Kitamura; Masaki Kobayashi; Osamu Kikuchi; Tsutomu Sasaki; Ronald A Depinho; Domenico Accili
Journal:  Mol Cell Biol       Date:  2009-06-08       Impact factor: 4.272

6.  Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.

Authors:  John P Morris; David A Cano; Shigeki Sekine; Sam C Wang; Matthias Hebrok
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

7.  Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.

Authors:  Carmen Guerra; Alberto J Schuhmacher; Marta Cañamero; Paul J Grippo; Lena Verdaguer; Lucía Pérez-Gallego; Pierre Dubus; Eric P Sandgren; Mariano Barbacid
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

8.  Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.

Authors:  Nilotpal Roy; Shivani Malik; Karina E Villanueva; Atsushi Urano; Xinyuan Lu; Guido Von Figura; E Scott Seeley; David W Dawson; Eric A Collisson; Matthias Hebrok
Journal:  Genes Dev       Date:  2015-03-15       Impact factor: 11.361

9.  An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data.

Authors:  Yuichi Shiraishi; Yusuke Sato; Kenichi Chiba; Yusuke Okuno; Yasunobu Nagata; Kenichi Yoshida; Norio Shiba; Yasuhide Hayashi; Haruki Kume; Yukio Homma; Masashi Sanada; Seishi Ogawa; Satoru Miyano
Journal:  Nucleic Acids Res       Date:  2013-03-06       Impact factor: 16.971

10.  Reduction of Ptf1a gene dosage causes pancreatic hypoplasia and diabetes in mice.

Authors:  Akihisa Fukuda; Yoshiya Kawaguchi; Kenichiro Furuyama; Sota Kodama; Masashi Horiguchi; Takeshi Kuhara; Michiya Kawaguchi; Mami Terao; Ryuichiro Doi; Christopher V E Wright; Mikio Hoshino; Tsutomu Chiba; Shinji Uemoto
Journal:  Diabetes       Date:  2008-06-30       Impact factor: 9.461

View more
  22 in total

Review 1.  Adult Pancreatic Acinar Progenitor-like Populations in Regeneration and Cancer.

Authors:  Zhengyu Jiang; Ruth A White; Timothy C Wang
Journal:  Trends Mol Med       Date:  2020-04-30       Impact factor: 11.951

Review 2.  Cell Type of Pancreatic Ductal Adenocarcinoma Origin: Implications for Prognosis and Clinical Outcomes.

Authors:  Shilpa Patil; Yan Dou; Janel L Kopp
Journal:  Visc Med       Date:  2021-12-27

3.  Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis.

Authors:  Hiroyuki Kato; Keisuke Tateishi; Hiroaki Fujiwara; Hideaki Ijichi; Keisuke Yamamoto; Takuma Nakatsuka; Miwako Kakiuchi; Makoto Sano; Yotaro Kudo; Yoku Hayakawa; Hayato Nakagawa; Yasuo Tanaka; Motoyuki Otsuka; Yoshihiro Hirata; Makoto Tachibana; Yoichi Shinkai; Kazuhiko Koike
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

4.  Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer.

Authors:  Nawab Azizi; Jelena Toma; Mickenzie Martin; Muhammad Faran Khalid; Fatemeh Mousavi; Phyo Wei Win; Maria Teresa Borrello; Nina Steele; Jiaqi Shi; Marina Pasca di Magliano; Christopher L Pin
Journal:  Oncogene       Date:  2021-04-16       Impact factor: 9.867

5.  BRG1 Is Dispensable for Sertoli Cell Development and Functions in Mice.

Authors:  Shuai Wang; Pengxiang Wang; Dongli Liang; Yuan Wang
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

6.  microRNA-690 regulates induced pluripotent stem cells (iPSCs) differentiation into insulin-producing cells by targeting Sox9.

Authors:  Yang Xu; Yan Huang; Yibing Guo; Yicheng Xiong; Shajun Zhu; Liancheng Xu; Jingjing Lu; Xiaohong Li; Jian Wan; Yuhua Lu; Zhiwei Wang
Journal:  Stem Cell Res Ther       Date:  2019-02-15       Impact factor: 6.832

7.  κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis.

Authors:  Stephanie Beel; Lina Kolloch; Lisa H Apken; Lara Jürgens; Andrea Bolle; Nadine Sudhof; Sankar Ghosh; Eva Wardelmann; Michael Meisterernst; Konrad Steinestel; Andrea Oeckinghaus
Journal:  Nat Commun       Date:  2020-07-08       Impact factor: 17.694

8.  HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties.

Authors:  Ethan V Abel; Masashi Goto; Brian Magnuson; Saji Abraham; Nikita Ramanathan; Emily Hotaling; Anthony A Alaniz; Chandan Kumar-Sinha; Michele L Dziubinski; Sumithra Urs; Lidong Wang; Jiaqi Shi; Meghna Waghray; Mats Ljungman; Howard C Crawford; Diane M Simeone
Journal:  Elife       Date:  2018-08-03       Impact factor: 8.140

Review 9.  The role of histone methylation in the development of digestive cancers: a potential direction for cancer management.

Authors:  Yuan Chen; Bo Ren; Jinshou Yang; Huanyu Wang; Gang Yang; Ruiyuan Xu; Lei You; Yupei Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-08-03

10.  5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma.

Authors:  Nancy D Ebelt; Edith Zuniga; Benjamin L Johnson; Don J Diamond; Edwin R Manuel
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.